CN Patent

CN101611032B — 作为抗糖尿病药的含噻吩基的吡喃葡糖基衍生物

Assigned to Janssen Pharmaceutica NV · Expires 2012-07-18 · 14y expired

What this patent protects

本发明涉及本文所述的式(I)化合物、其药学上可接受的盐，或其前药，以及药用组合物和治疗方法。

USPTO Abstract

本发明涉及本文所述的式(I)化合物、其药学上可接受的盐，或其前药，以及药用组合物和治疗方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101611032B
Jurisdiction
CN
Classification
—
Expires
2012-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.